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We	assessed	risk	factors	for	fetal	death	during	cholera	in-
fection	 and	 effect	 of	 treatment	 changes	 on	 these	 deaths.	
Third	 trimester	 gestation,	 younger	 maternal	 age,	 severe	
dehydration,	 and	 vomiting	 were	 risk	 factors.	 Changes	 in	
treatment	had	limited	effects	on	fetal	death,	highlighting	the	
need	for	prevention	and	evidence-based	treatment.
Cholera infections during pregnancy are associated with high rates of fetal death, especially when women are 
severely dehydrated (1–7). In Haiti in 2011, pregnant wom-
en with clinical signs of cholera who sought treatment from 
Médecins Sans Frontières (MSF) in Port-au-Prince were 
sent to a general cholera treatment center (CTC). In April 
2012, MSF established a CTC to improve fetal outcomes in 
pregnant women by facilitating intensive follow-up for de-
hydration and rapid access to obstetric and neonatal services. 
In June 2013, a more aggressive rehydration protocol was 
implemented (online Technical Appendix Table 1, http://
wwwnc.cdc.gov/EID/article/22/1/15-1078-Techapp1.pdf). 
To assess the effects of cholera infection, establishment 
of a specialized CTC, and the new rehydration protocol, 
we conducted a retrospective cohort analysis of pregnant 
women with suspected cholera admitted to MSF’s CTCs 
during September 1, 2011-December 31, 2014.
The Study
This study was approved by the National Bioethical Com-
mittee of the Ministry of Public Health and Population 
of Haiti. A cholera case-patient was defined as someone 
who passed >3 liquid stools with or without vomiting or 
dehydration in the previous 24 hours or within 6 hours of 
seeking treatment. Women of childbearing age were asked 
whether they were pregnant. Urine dipstick tests were con-
ducted in cases of uncertainty or early stages of pregnancy. 
Gestational age was determined by date of the woman’s 
last menstruation, uterine height, or ultrasound. Fetal sta-
tus was assessed at admission and hourly by using fetal 
stethoscope or ultrasonic fetal Doppler. Women who had 
a miscarriage at home and were not bleeding at admission 
were not classified as pregnant. Dehydration status was de-
termined according to World Health Organization catego-
ries (online Technical Appendix Table 1) (8). We assigned 
women into 3 treatment groups (TGs) according to whether 
they were treated in the general or specialized CTC and 
whether they were given the original or new protocol (on-
line Technical Appendix Table 1).
We analyzed fetal outcome for all pregnant women 
by initial signs and symptoms, TG, and clinical evolution. 
Multiple logistic regression modeling was used for adjust-
ed analyses. All analyses used Stata software version 12.0 
(StataCorp LP, College Station, TX, USA).
During September 1, 2011–December 31, 2014, a to-
tal of 936 pregnant women were admitted. Thirty-six were 
excluded from analysis: 33 (0.35%) lacked fetal outcome 
data, and 3 (0.03%) died (1 each during second and third 
trimester; for 1, trimester was unknown). Of the remain-
ing 900, mean age was 26.7 years (range 15–48, median 
26 years); 168 (18.9%) were in their first trimester, 303 
(34.2%) second trimester, and 416 (46.9%) third trimes-
ter. Trimester was unknown for 13. A total of 444 (49.3%) 
sought treatment within 24 hours of symptom development.
Fetal death occurred in 141 (15.7%) of the 900 ana-
lyzed pregnancies, more often in women <20 years of age 
(odds ratio [OR] 2.0, 95% CI 1.2–3.2), in their third trimes-
ter (OR 2.4, 95% CI 1.4–4.3), seeking treatment >24 hours 
after symptom onset (OR 1.5, 95% CI 1.0–2.2), with severe 
dehydration (OR 2.2, 95% CI 1.2–3.8), or who vomited 
(OR 2.1, 95% CI 1.3–3.5) (Table 1). A total of 64 (45.4%) 
fetal deaths occurred before admission.
Women who experienced preadmission or postadmis-
sion fetal death did not differ by age or clinical presentation 
(online Technical Appendix Table 2). However, preadmis-
sion fetal death was more likely in women who arrived >24 
hours after symptom onset (OR 1.9, 95% CI 0.9–4.1) or 
were severely dehydrated (OR 2.0, 95% CI 0.7–5.7). In 
unadjusted analysis, postadmission fetal death was associ-
ated with moderate dehydration (OR 2.1, 95% CI 1.2–3.6) 
and vomiting (OR 2.1, 95% CI 1.2–3.8; Table 2). Of 836 
women with a viable fetus at admission, 120 were in TG1, 
399 in TG2, and 317 in TG3.
There was no modification effect of TG on postadmis-
sion fetal death. Weak evidence of a difference in effect of 
Factors Related to Fetal Death in Pregnant 
Women with Cholera, Haiti, 2011–2014
124	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	22,	No.	1,	January	2016
Author	affiliations:	Médecins	Sans	Frontières,	Port-au-Prince,	 
Haiti	(E.	Schillberg,	L.	Bryson,	R.	Delva-Senat);	London	School	 
of	Hygiene	and	Tropical	Medicine,	London,	UK	(C.	Ariti);	 
Médecins	Sans	Frontières,	Amsterdam,	the	Netherlands	(D.	Price,	
A.	Lenglet);	Ministère	de	la	Santé	Publique	et	de	la	Population,	
Port-au-Prince	(R.	GrandPierre)
DOI:	http://dx.doi.org/10.3201/eid2201.151078
Fetal	Death	in	Pregnant	Women	with	Cholera,	Hait
severe dehydration on postadmission fetal death between 
TGs (p = 0.09) (Table 2) was potentially due to a lower rate 
among severely dehydrated women in TG2 (OR 0.4. 95% CI 
0.1–1.7; data not shown). However, there was insufficient 
power to detect these differences, and the final model did not 
require adjustment. Although the proportion of postadmis-
sion fetal deaths within a TG decreased with each protocol 
change, the proportion in TG3 (8.5%, 27/317) was not dif-
ferent from TG1 (10.0%, 12/120) or TG2 (9.5%, 38/399).
Conclusions
Fetal death occurred in 141 (16%) of 900 pregnancies. Risk 
factors were third trimester, younger maternal age, severe 
dehydration, and vomiting. Treatment in a specialized 
CTC and aggressive rehydration did not prevent fetal death 
though the trend was toward improved outcomes.
Severe dehydration at admission increased risk for fe-
tal death (2,5-7). Fetal death may occur due to fetal hypoxia 
and acidosis resulting from excessive maternal dehydration 
(2,4,9). The proportion of fetal deaths we found was higher 
than that previously recorded in Haiti (8%, 21/263) (2) but 
close to that of the 2006 Senegal cholera outbreak (12%, 
6/52) (3). Earlier studies in India (4), Nigeria (1,7), and 
Pakistan (6) found higher proportions.
Women <20 years of age were twice as likely as older 
women to experience fetal death. Although the relation-
ship between fetal death and maternal age during cholera 
has not been documented, younger age is associated with 
increased risk for other adverse pregnancy outcomes (10). 
The risk for fetal death was highest in the third trimester, 
even after controlling for maternal age, dehydration level, 
and vomiting. The relationship between fetal death and tri-
mester of pregnancy is unclear (1,3,6).
Determination of dehydration status of pregnant wom-
en is difficult in later stages of pregnancy (2,11). Misclas-
sification of dehydration status could affect fetal outcome 
due to placement of patients under the wrong treatment 
protocol. In addition, increased placental blood flow with 
gestational age may increase the effect of dehydration (12). 
Even after we controlled for dehydration level, we deter-
mined that fetal death was twice as likely in women expe-
riencing vomiting, potentially due to electrolyte changes in 
amniotic fluid (2,7,13–15).
Lack of effect of a specialized CTC on fetal death could 
result from a detection bias in that establishment of the spe-
cialized CTC led to an increased likelihood of detection of 
fetal deaths. In addition, 45% of fetal deaths occurred before 
women sought treatment. Fetal death may occur early in a 
pregnant woman’s illness with cholera (6), and more than 
half the women sought treatment >24 hours after symptom 
onset, likely contributing to poor fetal outcomes. Likewise, 
the effect of the new treatment protocol may have been lim-
ited by fetal death occurring before the women sought treat-
ment or by women being assigned the incorrect protocol due 
to difficulty in determining dehydration status.
Limitations include lack of laboratory-confirmed 
diagnoses. Data were collected for programmatic rath-
er than research purposes and lack electrolyte levels, 
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Table 1. Characteristics of	pregnant	cholera	patients	by	pregnancy	outcome	and	risk	factors,	Haiti,	2011–2014* 
Characteristic 
No.	(%)	fetal	
deaths,	n	=	141 
Unadjusted	analysis 
 
Adjusted	analysis† 
OR (95% CI)‡ p	value§ OR (95% CI)‡ p	value§ 
Age	group,	y       
 <20 30	(21.3) 2.08	(1.30–3.33) 0.01  1.98	(1.21–3.24) 0.02 
 20–34 96	(68.1) Referent Referent 
 ≥35 15	(10.6) 1.02	(0.57–1.83) 1.00	(0.55–1.84) 
 Missing 0   
Time	from	onset	to	admission,	h       
 ≤24 59	(41.8) Referent 0.04  Referent 0.04 
 >24 82	(58.2) 1.47	(1.02–2.12) 1.49	(1.02–2.17) 
 Missing 0   
Trimester	of	pregnancy       
 First 17	(12.1) Referent 0.02  Referent 0.001 
 Second 41	(29.1) 1.39	(0.76–2.53) 1.37	(0.74–2.53) 
 Third 79	(56.0) 2.08	(1.19–3.64) 2.43	(1.37–4.31) 
 Missing 4	(2.8)   
Dehydration	level       
 None 37	(26.2) Referent 0.001  Referent 0.02 
 Moderate 73	(51.8) 1.83	(0.20–2.79) 1.54	(0.99–2.41) 
 Severe 31	(22.0) 2.62	(1.55–4.44) 2.17	(1.24–3.81) 
 Missing 0   
Vomiting       
 Yes 116	(82.3) 2.25	(1.42–3.59) 0.001  2.10	(1.27–3.47) 0.001 
 No 24	(17.0) Referent Referent 
 Missing 1	(0.7)   
*Of	900	pregnancies	analyzed.	OR,	odds	ratio.	 
†Adjusted	for	all	list	characteristics. 
‡From	logistic	regression	model	with	fetal	death	as the	outcome	and	list	characteristics	as exposure. 
§From	Wald	tests	of	parameters	of	logistic	regression	model. 
 
DISPATCHES
amniotic fluid composition, maternal blood group, and fe-
tal cause of death. Some first-trimester pregnancies may 
have been missed. Pregnancies in women who completed 
miscarriage at home were not counted, potentially under-
estimating overall risk for fetal death. Because there was 
no follow-up of women after discharge, some early-term 
fetal deaths might have been missed. In addition, the long-
term effect of treatment on fetal well-being could not be 
determined. TG outcomes also may have been affected by 
differences in factors such as women’s access to health 
services over time.
Although the implementation of a specialized CTC 
did not decrease fetal deaths, specialized CTCs play a vi-
tal role in preserving patients’ dignity and providing pa-
tient-centered care. Determining the mechanism of fetal 
death in cholera infection would enable development of 
evidence-based treatment protocols. Because many fetal 
deaths occurred before women sought treatment, the im-
portance of cholera prevention and the risk for poor fetal 
outcomes should be emphasized.
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